Medication info
Rogetel Tablets 80/10/10 Milligrams

Rogetel Tablets 80/10/10 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
(Co., Ltd.) Green Cross
Appearance
Yellow oval film-coated tablets
Packaging
30 tablets/box [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202106687 · Approved 2021.09.29 · Insurance code 643606220

Summary

Main use
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
Who takes it
Adults
Adult dose
This drug is for use only in adults. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Telmisartan produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of telmisartan orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting telmisartan to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. • Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, measure blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. For patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly, switching to this drug (a combination tablet containing the same amounts of each active ingredient) may be considered for convenience.

Ingredients

Manufacturer
(Co., Ltd.) Green Cross

Efficacy & effects

Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular disease

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of end-organ damage
  • high-risk diabetes
  • primary hypercholesterolemia
  • heterozygous familial hyperlipidemia
  • non-familial dyslipidemia
  • mixed dyslipidemia
  • elevated total cholesterol
View approved original text

This medication is used for patients who need to take both Telmisartan and Rosuvastatin/Ezetimibe. Telmisartan helps in the treatment of essential hypertension and reduces the risk of cardiovascular disease. It lowers the risk of myocardial infarction, stroke, and mortality due to cardiovascular disease, especially in high-risk patients who cannot use ACE inhibitors. Rosuvastatin/Ezetimibe is used to improve blood lipid levels in patients with hypercholesterolemia and dyslipidemia. This medication reduces total cholesterol, LDL cholesterol, Apolipoprotein B, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol. Therefore, this medication is effective in managing both hypertension and hyperlipidemia while protecting cardiovascular health.

How to take

Adult dose

This drug is for use only in adults. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Telmisartan produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of telmisartan orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting telmisartan to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. • Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, measure blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. For patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly, switching to this drug (a combination tablet containing the same amounts of each active ingredient) may be considered for convenience.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it should be stopped immediately upon confirmation of pregnancy. Rhabdomyolysis, a muscle-related side effect, may occur rarely, so if you experience severe muscle pain or weakness, consult a doctor immediately. Patients with allergies to any of the components included in this medication, severely impaired liver or kidney function, and certain muscle diseases should not take this medication. Patients who consume alcohol excessively or have a history of liver disease should consult a doctor before taking this medication and should have regular liver function tests. This medication lowers blood pressure; therefore, if symptoms of hypotension occur, you should seek medical attention immediately and exercise caution when driving or operating machinery. During treatment, liver function, kidney function, and blood potassium levels should be periodically checked to monitor for any abnormalities. As there may be interactions with other medications, patients taking any other medications should inform their healthcare provider. During the treatment, if symptoms such as muscle pain, muscle cramps, or muscle weakness occur, inform your doctor immediately and undergo tests. Particularly, the elderly, patients with diabetes, and those with impaired kidney function should be more closely monitored for adverse reactions. This medication contains certain pigments, so patients with allergies to these components should consult their healthcare provider before taking it.

Side effects

Increased ALT, increased AST, increased Ɣ-GTP, increased ALP, abdominal pain, oral ulcers, vomiting, chest pain, palpitations, dizziness, shortness of breath, functional abnormalities of the Eustachian tube, tympanic membrane perforation, acute kidney injury, hematuria, shingles, pneumonia, non-small cell lung cancer, hair loss, dysuria, rhinitis, discomfort in the oropharynx, lung disease, unspecified colitis, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, chest pain, facial swelling, strange sensations, drug intolerance, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, cystitis, onychomycosis, soft tissue infection, liver steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased blood alkaline phosphatase, irregular heart rate, osteoarthritis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory disorders, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, headache, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, edema, decreased libido, facial edema, rash, alopecia, conjunctivitis, audible sounds in the ears, petechiae, fatigue, chest pain, chest discomfort, asthenia, systemic edema, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, constipation, dry mouth, discomfort in the epigastric region, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, cough, phlegm, runny nose, limb pain, joint pain, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, pruritus, upper respiratory tract infection, conjunctival congestion, renal failure, liver function abnormalities, increased blood creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reactions, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, abdominal pain, diarrhea, dyspepsia, abdominal distension, abdominal discomfort, dry mouth, abnormal liver function, liver disorders, increased sweating, itching, rash, erythema, vascular edema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, joint pain, limb pain, tendon pain, acute renal failure, asthenia, influenza-like illness, increased blood creatinine, increased blood uric acid, increased liver enzymes, increased serum creatine kinase, decreased hemoglobin, shock, loss of consciousness, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, insufficient effect, myalgia, myopathy, rhabdomyolysis, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, joint pain, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory impairment, forgetfulness, amnesia, memory disorders, confusion, severe myasthenia gravis, ocular myasthenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and humidity, so it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Yellow oval film-coated tablets

Package unit

30 tablets/box [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.